Novartis Said to Draw Interest for Vaccines Business
Tuesday, February 4, 2014
Novartis AG (NOVN) is drawing interest from potential bidders for its human-vaccines unit as talks to swap its animal-health business for assets from Merck & Co. (MRK) slow down, people with knowledge of the matter said.
Business For Sale in Boston News Snippet brought to you by: BizLocal.com
BizLocal provides a Business For Sale Market Place and more.
A web-property of Inspetta LLC, providing innovative web, software and marketing services to business.
Call 800-785-2925 for more information.